Biotech, Oncology, Clinical operations, Early development
Washington DC, US
I am happy to join Imagine having the expertise, leadership, and training in Medical Oncology, as well as drug-development, clinical trial operations and strong motivation necessary to successfully drive, mentor and design early and late stage medical projects.
I am a strong advocate for innovative treatment solutions that improve global access to care, and I have worked with different Massachusetts Institute of Technology (MIT) and Dana-Farber labs previously on solutions tested in US, Africa and India (e.g., PAP-smear mobile solutions, digital central mammogram screening apps, etc.).
I am currently Chief Scientific Officer and co-founder of Nanocan Therapeutics, a spin off out of Dana Farber working out of the Washington DC Office.